International Journal of Gynecologic Cancer: 34 (4)

Lead Article

Mirvetuximab soravtansine-gynx: first antibody/antigen-drug conjugate (ADC) in advanced or recurrent ovarian cancer (14 December, 2023) Free
Giorgio Bogani, Robert L Coleman, Ignace Vergote, Toon van Gorp, Isabelle Ray-Coquard, Ana Oaknin, Ursula Matulonis, David O’Malley, Francesco Raspagliesi, Giovanni Scambia, Bradley J Monk

Editorial

Mirvetuximab soravtansine: an oasis in the desert? (22 February, 2024) Free
Luisa Bonilla, Lawrence Kasherman, Luis Manso, Ainhoa Madariaga

Society statement

European Society of Gynaecological Oncology expanded quality indicators and accreditation for cervical cancer management (23 February, 2024)
Christina Fotopoulou, Ane Gerda Eriksson, François Planchamp, Philippe Morice, Alexandra Taylor, Alina Sturdza, Ovidiu Florin Coza, Michael J Halaska, Fabio Martinelli, Robert Armbrust, Cyrus Chargari

Cervical Cancer

Intraepithelial tumor-infiltrating lymphocytes shape loco-regional PET/CT spread of locally advanced cervical cancer (12 March, 2024)
Mathilde Del, Claire Illac, Mathilde Morisseau, Martina Aida Angeles, Anne Ducassou, Sarah Betrian, Guillaume Bataillon, Gwenael Ferron, Elodie Chantalat, Erwan Gabiache, Alejandra Martinez
Malnutrition is associated with poor survival in women receiving radiotherapy for cervical cancer (17 January, 2024)
Janna Laan, Luc van Lonkhuijzen, Karel Hinnen, Bradley Pieters, Inge Dekker, Lukas Stalpers, Henrike Westerveld
Consensus on surgical technique for sentinel lymph node dissection in cervical cancer (20 February, 2024)
Nicolò Bizzarri, Andreas Obermair, Heng-Cheng Hsu, Enrique Chacon, Anna Collins, Irina Tsibulak, Alex Mutombo, Nadeem R Abu-Rustum, Vincent Balaya, Alessandro Buda, David Cibula, Allan Covens, Francesco Fanfani, Gwenaël Ferron, Michael Frumovitz, Benedetta Guani, Roman Kocian, Christhardt Kohler, Eric Leblanc, Fabrice Lecuru, Mario M Leitao, Patrice Mathevet, Michael D Mueller, Andrea Papadia, Rene Pareja, Marie Plante, Denis Querleu, Giovanni Scambia, Edward Tanner, Ignacio Zapardiel, Jaime R Garcia, Pedro T Ramirez

Uterine Cancer

Intrauterine manipulator use during laparoscopic hysterectomy for endometrial cancer: association for pathological factors and oncologic outcomes (5 February, 2024) Free
Hiroshi Yoshida, Koji Matsuo, Hiroko Machida, Shinya Matsuzaki, Michihide Maeda, Yoshito Terai, Takuma Fujii, Masaki Mandai, Kei Kawana, Hiroaki Kobayashi, Mikio Mikami, Satoru Nagase
Therapeutic role of para-aortic lymphadenectomy in patients with intermediate- and high-risk endometrial cancer: a systematic review and meta-analysis (31 January, 2024)
Matteo Pavone, Floriane Jochum, Lise Lecointre, Francesco Fanfani, Giovanni Scambia, Denis Querleu, Chérif Akladios
Role of endometrial sampling to differentiate between advanced endometrial versus ovarian malignancy: retrospective cohort study (8 February, 2024)
Nguyen Thao Thi Nguyen, Nicole Diaz, Hadley Reid, Rebecca Previs, Laura J Havrilesky, Angeles Alvarez Secord, Andrew Berchuck
Mismatch repair status and surgical approach in apparent early-stage endometrial cancer (1 March, 2024)
Rhett Morton, Penelope M Webb, Renhua Na, Andreas Obermair, Rhonda Farrell
Recurrence rates and patterns of recurrence in stage IA p53abn endometrial cancer with and without myometrial invasion (22 February, 2024) Free
Amy Jamieson, Marcel Grube, Samuel Leung, Derek Chiu, Amy Lum, Janice S Kwon, Aline Talhouk, Blake Gilks, Stefan Kommoss, Jessica N McAlpine

Ovarian Cancer

Updated progression-free survival and final overall survival with maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial (21 December, 2023)
Domenica Lorusso, Marie-Ange Mouret-Reynier, Philipp Harter, Claire Cropet, Cristina Caballero, Pia Wolfrum-Ristau, Toyomi Satoh, Ignace Vergote, Gabriella Parma, Trine J Nøttrup, Coriolan Lebreton, Peter A Fasching, Carmela Pisano, Luis Manso, Hugues Bourgeois, Ingo Runnebaum, Claudio Zamagni, Anne-Claire Hardy-Bessard, Andreas Schnelzer, Michel Fabbro, Barbara Schmalfeldt, Dominique Berton, Antje Belau, Jean-Pierre Lotz, Martina Gropp-Meier, Laurence Gladieff, Hans-Joachim Lück, Sophie Abadie-Lacourtoisie, Eric Pujade-Lauraine, Isabelle Ray-Coquard
Medical cannabis and its effect on oncological outcomes in patients with ovarian cancer treated with PARP inhibitors (19 January, 2024)
Shira Peleg Hasson, Eliya Shachar, Miriam R Brezis, Akram Saad, Bar Toledano, Nadav Michaan, Ido Laskov, Dan Grisaru, Jeffrey Goldstein, Amir Nutman, Tamar Safra
Neuroendocrine neoplasms of the ovary: a review of 63 cases (30 January, 2024)
Alejandra Flores Legarreta, Reem Saab, Naomi R Gonzales, Gary B Chisholm, Shannon N Westin, R Tyler Hillman, Michael Frumovitz
Clinical impact of CA-125 ELIMination rate constant K (KELIM) on surgical strategy in advanced serous ovarian cancer patients (19 January, 2024)
Barnabe Bouvarel, Oliver Colomban, Jean-Sebastien Frenel, Cécile Loaec, Charlotte Bourgin, Dominique Berton, Gilles Freyer, Benoit You, Jean-Marc Classe
A computer synoptic operative report versus a report dictated by a surgeon in advanced ovarian cancer (8 February, 2024)
Alice Bedel, Guillaume Blache, Camille Jauffret, Gilles Houvenaeghel, Max Buttarelli, Laura Sabiani, Navid Mokarram Dorri, Houssein El Hajj, Eric Lambaudie

Therapeutics

Phase I study of ombrabulin in combination with paclitaxel and carboplatin in Japanese patients with advanced solid tumors (20 November, 2023)
Koji Matsumoto, Yoshinori Sunaga, Evelyne Ecstein-Fraisse, Keiichi Fujiwara
Procedural interventions for oligoprogression during treatment with immune checkpoint blockade in gynecologic malignancies: a case series (31 January, 2024) Free
Tiffany Y Sia, Vivian Wan, Michael Finlan, Qin C Zhou, Alexia Iasonos, Oliver Zivanovic, Yukio Sonoda, Dennis S Chi, Kara Long Roche, Elizabeth Jewell, William P Tew, Roisin E O'Cearbhaill, Seth Cohen, Vicky Makker, Ying L Liu, Claire F Friedman, Chrisann Kyi, Dmitriy Zamarin, Ginger Gardner

Surgery

Predictors and outcomes of same day discharge after minimally invasive hysterectomy in gynecologic oncology within the National Surgical Quality Improvement Program database (14 December, 2023)
Tal Milman, Azusa Maeda, Brenna E Swift, Geneviève Bouchard-Fortier

Reviews

Best original research presented at the 24^th European Congress on Gynaecological Oncology—Best of ESGO 2023
(7 December, 2023)
Joanna Kacperczyk-Bartnik, Nicolò Bizzarri, Tibor Andrea Zwimpfer, Houssein El Hajj, Martina Aida Angeles, Richard Tóth, Charalampos Theofanakis, Esra Bilir, Khayal Gasimli, Aleksandra Natalia Strojna, Tanja Nikolova, Ali Ayhan, Domenica Lorusso, Luis Chiva
Training the gynecologic oncologists of the future – challenges and opportunities (20 November, 2023)
Ben-Lawrence Kemah, Nanak Bhagat, Aayushi Pandya, Richard Sullivan, Sudha S Sundar

Clinical trial

A phase II, multicenter, open-label study of abemaciclib and letrozole in patients with estrogen receptor-positive rare ovarian cancer: ALEPRO trial (6 March, 2024)
Tine Ottenbourgs, Toon van Gorp, Frédéric Kridelka, Thaïs Baert, Hannelore Denys, Frédéric Selle, Inge Baas, Anne-Sophie Van Rompuy, Diether Lambrechts, Els Van Nieuwenhuysen

Tumor board

Management challenges in low-grade serous ovarian cancer with a BRCA mutation (1 April, 2024) Free
Luisa Sanchez-Lorenzo, Lidia Sancho, Teresa Iscar, Rachel Grisham, Luis Chiva

Corners of the world

The International Gynecologic Cancer Society Preinvasive Certificate Program: building a skilled workforce for the detection and treatment of cervical pre-cancer (12 February, 2024) Free
Karen Haney, Ida Ismail-Pratt, Joseph Soon-Yau Ng, Kathleen M Schmeler, Mila Pontremoli Salcedo

Video Articles

Alternatives of the pelvic sentinel lymph node migration pathway in early ovarian cancer: the simplest the best (9 November, 2023) Free
Victor Lago, Marta Arnaez, Pablo Padilla-Iserte, Alberto Rafael Guijarro-Campillo, Luis Matute, Marta Gurrea, Pilar Bello, Santiago Domingo
Laparoscopic sigmoidectomy with ghost ileostomy in ovarian cancer recurrence (16 November, 2023) Free
Pablo Padilla-Iserte, Manel Montesinos-Albert, Marta Arnaez, Victor Lago, Matteo Frasson, Luis Matute, Santiago Domingo
Use of indocyanine green for ureteric illumination and visualization (22 January, 2024) Free
Helena M Obermair, Santiago Scasso, Joel Laufer, Andreas Obermair

Pathology archives

Clinical and pathological overview of endometrial endometrioid carcinoma (18 October, 2023)
Mohamed Maher, Breann Angelica Zeches, Anas Mohamed

Images

Laparoscopic para-aortic lymphadenectomy in cases of retro-aortic left renal vein (22 November, 2023)
Giuseppe Cucinella, Vito Chiantera

Commentaries

Who takes care of the patient? Ovarian cancer management in an ESGO ovarian cancer center of excellence (17 January, 2024)
David Johannes Krankenberg, Jalid Sehouli
Benign Brenner tumor pathology: the ‘dragon fruit sign’ (22 February, 2024)
Paytra A Klein, Amelia Stapleton Van Doren, Johanna Bringley

Letters

Correspondence on “Sentinel lymph node assessment in patients with atypical endometrial hyperplasia: a systematic review and meta-analysis” by Vieira-Serna et al (11 March, 2024)
X Mona Guo, Lauren M Lim, Koji Matsuo
Response to: Correspondence on “Sentinel lymph node assessment in patients with atypical endometrial hyperplasia: a systematic review and meta-analysis” by Vieira-Serna et al and Restaino et al (11 March, 2024)
Santiago Vieira-Serna, David Viveros-Carreño, Rene Pareja
Correspondence on ‘Sentinel lymph node assessment in patients with atypical endometrial hyperplasia: a systematic review and meta-analysis’ by Vieira-Serna et al (11 March, 2024)
Stefano Restaino, Martina Arcieri, Giuseppe Vizzielli

Miscellaneous

Correction: MILACC study: could undetected lymph node micrometastases have impacted recurrence rate in the LACC trial?
(1 April, 2024) Free

Main menu

Table of contents

April 2024 - Volume 34 - 4

Lead Article

Editorial

Society statement

Cervical Cancer

Uterine Cancer

Ovarian Cancer

Therapeutics

Surgery

Reviews

Clinical trial

Tumor board

Corners of the world

Video Articles

Pathology archives

Images

Commentaries

Letters

Miscellaneous

Issue Information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Table of contents

April 2024 - Volume 34 - 4

Lead Article

Editorial

Society statement

Cervical Cancer

Uterine Cancer

Ovarian Cancer

Therapeutics

Surgery

Reviews

Clinical trial

Tumor board

Corners of the world

Video Articles

Pathology archives

Images

Commentaries

Letters

Miscellaneous

Issue Information